{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:24:39Z","timestamp":1794223479505,"version":"4.8.0"},"reference-count":204,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.expneurol.2026.115703","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:03:33Z","timestamp":1772093013000},"page":"115703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Mitochondrial dysfunction and disrupted neuronal lipid homeostasis in Parkinson\u2019s disease: Potential mechanisms and therapeutic implications"],"prefix":"10.1016","volume":"400","author":[{"given":"Zehao","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yuan","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Tin","family":"Fok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Oluwatobi","family":"Akefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/15548627.2018.1537769","article-title":"MTOR-independent autophagy induced by interrupted endoplasmic reticulum-mitochondrial Ca2+ communication: a dead end in cancer cells","volume":"15","author":"Ahumada-Castro","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2026.115703_bb0010","series-title":"Molecular Mechanisms of Neurotransmitter Release","first-page":"357","article-title":"Lipids and secretory vesicle exocytosis","author":"Akefe","year":"2023"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s44318-024-00030-7","article-title":"The DDHD2-STXBP1 interaction mediates long-term memory via generation of saturated free fatty acids","volume":"43","author":"Akefe","year":"2024","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14305","article-title":"Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways","volume":"1467","author":"Al-Bari","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2026.115703_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnins.2019.00328","article-title":"Dysregulated lipid metabolism and its role in \u03b1-Synucleinopathy in Parkinson\u2019s disease","volume":"13","author":"Alecu","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41531-023-00496-y","article-title":"Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson\u2019s disease","volume":"9","author":"Alvarez Jerez","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0035","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1242\/jcs.180737","article-title":"Ca2+ is a key factor in \u03b1-synuclein-induced neurotoxicity","volume":"129","author":"Angelova","year":"2016","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2006476118","article-title":"The Parkinson\u2019s disease-associated gene ITPKB protects against \u03b1-synuclein aggregation by regulating ER-to-mitochondria calcium release","volume":"118","author":"Apicco","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molcel.2017.07.019","article-title":"Systematic identification of MCU modulators by orthogonal interspecies chemical screening","volume":"67","author":"Arduino","year":"2017","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00441-016-2463-1","article-title":"Mitochondrial lipids in neurodegeneration","volume":"367","author":"Aufschnaiter","year":"2017","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.expneurol.2026.115703_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0060","first-page":"103","article-title":"The role of alpha-synuclein in synucleinopathy: impact on lipid regulation at mitochondria\u2013ER membranes. Npj","volume":"11","author":"Barbuti","year":"2025","journal-title":"Parkinson\u2019s Disease"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0065","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1471-4159.2008.05254.x","article-title":"Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson\u2019s disease","volume":"105","author":"Bar-On","year":"2008","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.expneurol.2026.115703_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713270","article-title":"The bidirectional interplay of \u03b1-Synuclein with lipids in the central nervous system and its implications for the pathogenesis of Parkinson\u2019s disease","volume":"24","author":"Battis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-6-8","article-title":"Glutathione peroxidase 4 is associated with Neuromelanin in substantia Nigra and dystrophic axons in putamen of Parkinson\u2019s brain","volume":"6","author":"Bellinger","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2200345","article-title":"Inositol trisphosphate and diacylglycerol as second messengers","volume":"220","author":"Berridge","year":"1984","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0085","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201744617","article-title":"Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation","volume":"19","author":"Betzer","year":"2018","journal-title":"EMBO Rep."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0090","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson\u2019s disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain: A J. Neurol."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115703_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112514","article-title":"Prospects for the development of Pink1 and parkin activators for the treatment of Parkinson\u2019s disease","volume":"14","author":"Blagov","year":"2022","journal-title":"Pharmaceutics"},{"issue":"27","key":"10.1016\/j.expneurol.2026.115703_bb0100","doi-asserted-by":"crossref","first-page":"23977","DOI":"10.1074\/jbc.C200171200","article-title":"AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling","volume":"277","author":"Bolster","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5\u20136","key":"10.1016\/j.expneurol.2026.115703_bb0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0143416002002002","article-title":"The endoplasmic reticulum is a focal point for co-ordination of cellular activity","volume":"32","author":"Bootman","year":"2002","journal-title":"Cell Calcium"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115703_bb0110","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1042\/BST20130130","article-title":"\u03b1-Synuclein as a ferrireductase","volume":"41","author":"Brown","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2026.115703_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4130937","article-title":"\u0394 -opioid receptor activation inhibits Ferroptosis by activating the Nrf2 pathway in MPTP-induced Parkinson disease models","volume":"2023","author":"Cai","year":"2023","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"2\u20133","key":"10.1016\/j.expneurol.2026.115703_bb0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12017-017-8447-9","article-title":"Deferiprone rescues Behavioral deficits induced by mild Iron exposure in a mouse model of alpha-Synuclein aggregation","volume":"19","author":"Carboni","year":"2017","journal-title":"NeuroMolecular Med."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166980","article-title":"NPC1-like phenotype, with intracellular cholesterol accumulation and altered mTORC1 signaling in models of Parkinson\u2019s disease","volume":"1870","author":"Caria","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0130","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1042\/BCJ20160780","article-title":"The lysosome: a crucial hub for AMPK and mTORC1 signalling","volume":"474","author":"Carroll","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2026.115703_bb0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2017.10.031","article-title":"Lowered iPLA(2)\u03b3 activity causes increased mitochondrial lipid peroxidation and mitochondrial dysfunction in a rotenone-induced model of Parkinson\u2019s disease","volume":"300","author":"Chao","year":"2018","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115703_bb0140","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/cns.14130","article-title":"Srs11-92, a ferrostatin-1 analog, improves oxidative stress and neuroinflammation via Nrf2 signal following cerebral ischemia\/reperfusion injury","volume":"29","author":"Chen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2026.115703_bb0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuro.2021.11.003","article-title":"Mitochondrial iron metabolism and neurodegenerative diseases","volume":"88","author":"Cheng","year":"2022","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0150","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1152\/ajpcell.00243.2006","article-title":"Role of cardiolipin alterations in mitochondrial dysfunction and disease","volume":"292","author":"Chicco","year":"2007","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.expneurol.2026.115703_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fncel.2015.00124","article-title":"Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases","volume":"9","author":"Chin-Chan","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0160","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","article-title":"Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity","volume":"25","author":"Choi","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0165","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","article-title":"Survival and dementia in GBA-associated Parkinson\u2019s disease: the mutation matters","volume":"80","author":"Cilia","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2026.115703_bb0170","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399410001742","article-title":"Endoplasmic reticulum stress and lipid dysregulation","volume":"13","author":"Colgan","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2023-000535","article-title":"Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol","volume":"5","author":"Colucci","year":"2023","journal-title":"BMJ Neurol. Open"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115703_bb0180","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1083\/jcb.200604016","article-title":"Structural and functional features and significance of the physical linkage between ER and mitochondria","volume":"174","author":"Csord\u00e1s","year":"2006","journal-title":"J. Cell Biol."},{"issue":"22","key":"10.1016\/j.expneurol.2026.115703_bb0185","doi-asserted-by":"crossref","first-page":"16655","DOI":"10.1016\/S0021-9258(19)85468-6","article-title":"Cloning and expression of a novel phosphatidylethanolamine N-methyltransferase. A specific biochemical and cytological marker for a unique membrane fraction in rat liver","volume":"268","author":"Cui","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115703_bb0190","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/900a5247-7d03-4686-a544-5f7f64c0aac5","article-title":"Alpha-Synuclein is a cellular Ferrireductase","volume":"6","author":"Davies","year":"2011","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.expneurol.2026.115703_bb0200","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson\u2019s disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"22","key":"10.1016\/j.expneurol.2026.115703_bb0210","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of Deferiprone in Parkinson\u2019s disease","volume":"387","author":"Devos","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0220","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2026.115703_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0230","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/cancers11101422","article-title":"The emerging roles of mTORC1 in macromanaging autophagy","volume":"11","author":"Dossou","year":"2019","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.expneurol.2026.115703_bb0235","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.freeradbiomed.2011.05.009","article-title":"Ironing out neurodegeneration: iron chelation for neuroprotection","volume":"51","author":"Dunaief","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejcb.2017.01.002","article-title":"Impact of high cholesterol in a Parkinson\u2019s disease model: prevention of lysosomal leakage versus stimulation of \u03b1-synuclein aggregation","volume":"96","author":"Eriksson","year":"2017","journal-title":"Eur. J. Cell Biol."},{"issue":"14","key":"10.1016\/j.expneurol.2026.115703_bb0245","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences","volume":"31","author":"Exner","year":"2012","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115703_bb0250","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3390\/molecules23071531","article-title":"\u03b1-Synuclein and polyunsaturated fatty acids: molecular basis of the interaction and implication in neurodegeneration","volume":"23","author":"Fecchio","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: how does lipid peroxidation cause ferroptosis?","volume":"16","author":"Feng","year":"2018","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13010112","article-title":"Mitochondrial and endoplasmic reticulum stress trigger triglyceride accumulation in models of Parkinson\u2019s disease independent of mutations in MAPT","volume":"13","author":"Fernandes","year":"2023","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0265","article-title":"A perspective on the link between mitochondria-associated membranes (MAMs) and lipid droplets metabolism in neurodegenerative diseases","volume":"12","author":"Fernandes","year":"2023","journal-title":"Biol.-Basel"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115703_bb0270","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0275","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2011.12.022","article-title":"The role of cholesterol in the association of endoplasmic reticulum membranes with mitochondria","volume":"417","author":"Fujimoto","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0280","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneurol.2011.1060","article-title":"Prospective study of statin use and risk of Parkinson disease","volume":"69","author":"Gao","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2026.115703_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.938686","article-title":"On disease modifying and neuroprotective treatments for Parkinson\u2019s disease: physical exercise","volume":"13","author":"Garcia Ruiz","year":"2022","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115703_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065470","article-title":"Microarrays, enzymatic assays, and MALDI-MS for determining specific alterations to mitochondrial Electron transport chain activity, ROS formation, and lipid composition in a monkey model of Parkinson\u2019s disease","volume":"24","author":"Garc\u00eda-Fern\u00e1ndez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0295","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/mds.28396","article-title":"The role of cholesterol in \u03b1-Synuclein and Lewy body pathology in GBA1 Parkinson\u2019s disease","volume":"36","author":"Garc\u00eda-Sanz","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2026.115703_bb0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fnins.2019.00329","article-title":"Lipidomic alterations in the mitochondria of aged parkin null mice relevant to autophagy","volume":"13","author":"Gaudioso","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0305","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0310","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.4103\/1673-5374.369111","article-title":"The importance of being connected: membrane contact sites and Parkinson\u2019s disease","volume":"18","author":"Gegg","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"6\u20137","key":"10.1016\/j.expneurol.2026.115703_bb0315","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbabio.2010.02.005","article-title":"The regulation of OXPHOS by extramitochondrial calcium","volume":"1797","author":"Gellerich","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.expneurol.2026.115703_bb0320","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1021\/acschemneuro.9b00320","article-title":"Cardiolipin promotes pore-forming activity of alpha-Synuclein oligomers in mitochondrial membranes","volume":"10","author":"Ghio","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0325","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/cdd.2016.52","article-title":"The coming of age of the mitochondria-ER contact: a matter of thickness","volume":"23","author":"Giacomello","year":"2016","journal-title":"Cell Death Differ."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2026.115703_bb0330","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/bj3580147","article-title":"Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function","volume":"358","author":"Gincel","year":"2001","journal-title":"Biochem. J."},{"issue":"6a","key":"10.1016\/j.expneurol.2026.115703_bb0335","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1582-4934.2008.00402.x","article-title":"Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling","volume":"12","author":"Gorman","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115703_bb0340","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.26239","article-title":"A new role for \u03b1-synuclein in Parkinson\u2019s disease: alteration of ER-mitochondrial communication","volume":"30","author":"Guardia-Laguarta","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2026.115703_bb0345","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fnins.2018.00397","article-title":"Plin4-dependent lipid droplets hamper neuronal Mitophagy in the MPTP\/p-induced mouse model of Parkinson\u2019s disease","volume":"12","author":"Han","year":"2018","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0350","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.200802164","article-title":"CaM kinase I\u03b1\u2013induced phosphorylation of Drp1 regulates mitochondrial morphology","volume":"182","author":"Han","year":"2008","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115703_bb0355","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202106046","article-title":"ER-lysosome lipid transfer protein VPS13C\/PARK23 prevents aberrant mtDNA-dependent STING signaling","volume":"221","author":"Hancock-Cerutti","year":"2022","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"44","key":"10.1016\/j.expneurol.2026.115703_bb0365","doi-asserted-by":"crossref","first-page":"27879","DOI":"10.1074\/jbc.271.44.27879","article-title":"Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase","volume":"271","author":"Hawley","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0370","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax8352","article-title":"Mitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity","volume":"5","author":"Heden","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0375","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0380","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201909154","article-title":"Mitochondrial fragmentation enables localized signaling required for cell repair","volume":"219","author":"Horn","year":"2020","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113244","article-title":"\u03b1-Synuclein-dependent increases in PIP5K1\u03b3 drive inositol signaling to promote neurotoxicity","volume":"42","author":"Horvath","year":"2023","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0390","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.plipres.2013.07.002","article-title":"Lipids of mitochondria","volume":"52","author":"Horvath","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0395","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209137","article-title":"Cinpanemab in early Parkinson disease: evaluation of biomarker results from the phase 2 SPARK clinical trial","volume":"102","author":"Hutchison","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2026.115703_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1302472","article-title":"Sphingolipids in mitochondria\u2014from function to disease","volume":"11","author":"Jamil","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0405","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.201008084","article-title":"Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL","volume":"191","author":"Jin","year":"2010","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0410","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10495-009-0452-5","article-title":"Regulation of apoptosis-associated lysosomal membrane permeabilization","volume":"15","author":"Johansson","year":"2010","journal-title":"Apoptosis"},{"issue":"21","key":"10.1016\/j.expneurol.2026.115703_bb0415","doi-asserted-by":"crossref","first-page":"17589","DOI":"10.1074\/jbc.M111.330167","article-title":"Cardiolipin and mitochondrial phosphatidylethanolamine have overlapping functions in mitochondrial fusion in Saccharomyces cerevisiae","volume":"287","author":"Joshi","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0420","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1096\/fj.00-0708fje","article-title":"The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress","volume":"15","author":"K\u00e5gedal","year":"2001","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115703_bb0425","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41582-024-01023-0","article-title":"Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis","volume":"20","author":"Kalia","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0430","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1083\/jcb.201402104","article-title":"PINK1 phosphorylates ubiquitin to activate parkin E3 ubiquitin ligase activity","volume":"205","author":"Kane","year":"2014","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0435","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbamcr.2014.03.022","article-title":"Calcium trafficking integrates endoplasmic reticulum function with mitochondrial bioenergetics","volume":"1843","author":"Kaufman","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115703_bb0440","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson\u2019s disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"issue":"21","key":"10.1016\/j.expneurol.2026.115703_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/cells12212550","article-title":"LRRK2 attenuates antioxidant response in familial Parkinson\u2019s disease derived neural stem cells","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2026.115703_bb0450","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/DDDT.S79458","article-title":"Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes","volume":"10","author":"Kontoghiorghe","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"5939","key":"10.1016\/j.expneurol.2026.115703_bb0455","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1175088","article-title":"An ER-mitochondria tethering complex revealed by a synthetic biology screen","volume":"325","author":"Kornmann","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0460","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.celrep.2015.08.079","article-title":"PKA phosphorylation of NCLX reverses mitochondrial calcium overload and depolarization, promoting survival of PINK1-deficient dopaminergic neurons","volume":"13","author":"Kostic","year":"2015","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115703_bb0465","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1042\/EBC20210017","article-title":"Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer\u2019s disease","volume":"65","author":"Lane","year":"2021","journal-title":"Essays Biochem."},{"issue":"1\u20133","key":"10.1016\/j.expneurol.2026.115703_bb0470","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/ars.2023.0318","article-title":"Striking a NRF2: the rusty and rancid vulnerabilities toward Ferroptosis in Alzheimer\u2019s disease","volume":"39","author":"Lane","year":"2023","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2026.115703_bb0475","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of Cinpanemab in early Parkinson\u2019s disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0480","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14802\/jmd.15059","article-title":"Mechanism of anti-\u03b1-Synuclein immunotherapy","volume":"9","author":"Lee","year":"2016","journal-title":"J. Mov. Disord."},{"issue":"41","key":"10.1016\/j.expneurol.2026.115703_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409329","article-title":"Targeting the labile iron pool with engineered DFO nanosheets to inhibit ferroptosis for Parkinson\u2019s disease therapy","volume":"36","author":"Lei","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.expneurol.2026.115703_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104021","article-title":"Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: a randomised, double-blind, placebo-controlled phase 1a trial","volume":"80","author":"Levin","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0495","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2026.115703_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101817","article-title":"PINK1\/parkin-mediated mitophagy in neurodegenerative diseases","volume":"84","author":"Li","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0505","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12906-023-03967-0","article-title":"Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson's disease via inhibiting oxidative stress and ferroptosis","volume":"23","author":"Li","year":"2023","journal-title":"BMC Compl. Med. Ther."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0510","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4894","article-title":"miR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson\u2019s disease","volume":"47","author":"Li","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.expneurol.2026.115703_bb0515","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41420-024-01918-3","article-title":"Mitochondria-associated endoplasmic reticulum membrane (MAM): a dark horse for diabetic cardiomyopathy treatment","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115703_bb0520","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1080\/15548627.2020.1839191","article-title":"Macrophage mitochondrial MFN2 (mitofusin 2) links immune stress and immune response through reactive oxygen species (ROS) production","volume":"16","author":"Lloberas","year":"2020","journal-title":"Autophagy"},{"issue":"13","key":"10.1016\/j.expneurol.2026.115703_bb0525","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","article-title":"cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain","volume":"96","author":"Lund","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.115703_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1498756","article-title":"Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the global burden of disease study 2021","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115703_bb0535","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41419-023-06251-8","article-title":"Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization","volume":"14","author":"Lurette","year":"2023","journal-title":"Cell Death Dis."},{"issue":"31","key":"10.1016\/j.expneurol.2026.115703_bb0540","doi-asserted-by":"crossref","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","article-title":"Soluble, prefibrillar \u03b1-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction","volume":"289","author":"Luth","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2017.7115","article-title":"GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues","volume":"29","author":"Maiorino","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0550","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40478-024-01742-x","article-title":"Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD\/ALS mutant TDP43 linked Ca(2+) and synaptic defects","volume":"12","author":"Markovinovic","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115703_bb0555","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06290-1","article-title":"Negative modulation of mitochondrial calcium uniporter complex protects neurons against ferroptosis","volume":"14","author":"Marmolejo-Garza","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0560","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0565","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/antiox11050801","article-title":"Mitochondrial calcium: effects of its imbalance in disease","volume":"11","author":"Matuz-Mares","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.expneurol.2026.115703_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2017.08.001","article-title":"Alpha-synuclein ferrireductase activity is detectible <i>in vivo<\/i>, is altered in Parkinson\u2019s disease and increases the neurotoxicity of DOPAL","volume":"85","author":"McDowall","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115703_bb0575","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.7150\/thno.98457","article-title":"The biphasic role of Hspb1 on ferroptotic cell death in Parkinson's disease","volume":"14","author":"Meng","year":"2024","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115703_bb0580","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1194\/jlr.RA120000628","article-title":"Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis[S]","volume":"61","author":"Mignard","year":"2020","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115703_bb0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131071","article-title":"Inhibition of the inositol kinase Itpkb augments calcium signaling in lymphocytes and reveals a novel strategy to treat autoimmune disease","volume":"10","author":"Miller","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115703_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126622","article-title":"The effect of neuronal CoQ10 deficiency and mitochondrial dysfunction on a rotenone-induced neuronal cell model of Parkinson\u2019s disease","volume":"25","author":"Millichap","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309893","article-title":"Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson\u2019s disease","volume":"19","author":"Minnella","year":"2024","journal-title":"PLoS One"},{"issue":"41","key":"10.1016\/j.expneurol.2026.115703_bb0600","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1073\/pnas.1902958116","article-title":"Parkinson\u2019s disease-associated iPLA2-VIA\/PLA2G6 regulates neuronal functions and \u03b1-synuclein stability through membrane remodeling","volume":"116","author":"Mori","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10423","key":"10.1016\/j.expneurol.2026.115703_bb0605","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001977","article-title":"An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets","volume":"21","author":"Moskal","year":"2023","journal-title":"PLoS Biol."},{"issue":"17","key":"10.1016\/j.expneurol.2026.115703_bb0615","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1038\/emboj.2013.168","article-title":"Mfn2 modulates the UPR and mitochondrial function via repression of PERK","volume":"32","author":"Mu\u00f1oz","year":"2013","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000298","article-title":"PINK1 is selectively stabilized on impaired mitochondria to activate parkin","volume":"8","author":"Narendra","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2026.115703_bb0625","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41531-022-00397-6","article-title":"Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology","volume":"8","author":"Navarro-Romero","year":"2022","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0630","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14607","article-title":"Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"30","author":"Negida","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2026.115703_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107257","article-title":"A phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson\u2019s disease (PADOVA): rationale, design, and baseline data","volume":"132","author":"Nikolcheva","year":"2025","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2026.115703_bb0640","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bj3510183","article-title":"Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis","volume":"351","author":"Nomura","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2026.115703_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105917","article-title":"LRRK2 protects immune cells against erastin-induced ferroptosis","volume":"175","author":"Oun","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0650","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of Prasinezumab in early-stage Parkinson\u2019s disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0655","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-017-1704-z","article-title":"\u03b1-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production","volume":"134","author":"Paillusson","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030770","article-title":"Current treatments and new, tentative therapies for Parkinson\u2019s disease","volume":"15","author":"Pardo-Moreno","year":"2023","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.expneurol.2026.115703_bb0665","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1021\/acschemneuro.0c00309","article-title":"Real-time characterization of cell membrane disruption by \u03b1-synuclein oligomers in live SH-SY5Y neuroblastoma cells","volume":"11","author":"Parres-Gold","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0670","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-811X-10-17","article-title":"Role of the inositol 1,4,5-trisphosphate receptor\/Ca2+-release channel in autophagy","volume":"10","author":"Parys","year":"2012","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.expneurol.2026.115703_bb0675","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1478-811X-9-19","article-title":"Calcium signaling around mitochondria associated membranes (MAMs)","volume":"9","author":"Patergnani","year":"2011","journal-title":"Cell Commun. Signal"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0680","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jinorgbio.2009.11.005","article-title":"Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes","volume":"104","author":"Peng","year":"2010","journal-title":"J. Inorg. Biochem."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0685","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0005-2736(03)00024-5","article-title":"Role of cholesterol in synapse formation and function","volume":"1610","author":"Pfrieger","year":"2003","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0690","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0695","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuron.2015.06.034","article-title":"Endogenous parkin preserves dopaminergic substantia Nigral neurons following mitochondrial DNA mutagenic stress","volume":"87","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0700","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0705","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1007\/s12035-023-03400-0","article-title":"Presence of extracellular alpha-Synuclein aggregates trigger astrocytic degeneration through enhanced membrane rigidity and deregulation of store-operated calcium entry (SOCE) into the endoplasmic reticulum","volume":"60","author":"Raj","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0710","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000481551","article-title":"1-Methyl-4-Phenylpyridinium-induced death of differentiated SH-SY5Y neurons is potentiated by cholesterol","volume":"24","author":"Raju","year":"2018","journal-title":"Ann. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0715","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neurosci."},{"issue":"Pt B","key":"10.1016\/j.expneurol.2026.115703_bb0720","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115703_bb0725","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1007\/s12035-016-0140-8","article-title":"Mitochondria-associated membranes (MAMs): overview and its role in Parkinson\u2019s disease","volume":"54","author":"Rodr\u00edguez-Arribas","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"35","key":"10.1016\/j.expneurol.2026.115703_bb0730","doi-asserted-by":"crossref","first-page":"29589","DOI":"10.1074\/jbc.M112.378778","article-title":"Membrane lipid composition regulates tubulin interaction with mitochondrial voltage-dependent Anion Channel","volume":"287","author":"Rostovtseva","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111772","article-title":"Essential role of the mitochondrial Na+\/Ca2+ exchanger NCLX in mediating PDE2-dependent neuronal survival and learning","volume":"41","author":"Rozenfeld","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0740","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41467-018-03241-9","article-title":"Cardiolipin exposure on the outer mitochondrial membrane modulates \u03b1-synuclein","volume":"9","author":"Ryan","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0745","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092452","article-title":"Alpha-Synuclein and lipids: the elephant in the room?","volume":"10","author":"Sarchione","year":"2021","journal-title":"Cells"},{"issue":"52","key":"10.1016\/j.expneurol.2026.115703_bb0750","doi-asserted-by":"crossref","first-page":"18076","DOI":"10.1074\/jbc.RA120.015319","article-title":"\u03b1-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate","volume":"295","author":"Schechter","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0755","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14348\/molcells.2023.0005","article-title":"Anti-Ferroptotic effects of Nrf2: beyond the antioxidant response","volume":"46","author":"Shakya","year":"2023","journal-title":"Mol. Cell"},{"issue":"50","key":"10.1016\/j.expneurol.2026.115703_bb0760","doi-asserted-by":"crossref","first-page":"49874","DOI":"10.1074\/jbc.M309127200","article-title":"Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies","volume":"278","author":"Sharon","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0765","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s11064-024-04116-w","article-title":"Salidroside mediated the Nrf2\/GPX4 pathway to attenuates Ferroptosis in Parkinson\u2019s disease","volume":"49","author":"Shen","year":"2024","journal-title":"Neurochem. Res."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115703_bb0770","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"issue":"13","key":"10.1016\/j.expneurol.2026.115703_bb0775","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.3390\/ijms25137102","article-title":"GBA1-associated Parkinson\u2019s disease is a distinct entity","volume":"25","author":"Skrahin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0780","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/mds.29170","article-title":"Phase 1\/1b studies of UCB0599, an Oral inhibitor of \u03b1-Synuclein Misfolding, including a randomized study in Parkinson\u2019s disease","volume":"37","author":"Smit","year":"2022","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0785","article-title":"Restriction of mitochondrial calcium overload by mcu inactivation renders a neuroprotective effect in zebrafish models of Parkinson\u2019s disease","volume":"8","author":"Soman","year":"2019","journal-title":"Biol. Open"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0790","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/bph.14881","article-title":"Cu(II) (atsm) inhibits ferroptosis: implications for treatment of neurodegenerative disease","volume":"177","author":"Southon","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0795","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/1673-5374.198970","article-title":"Endoplasmic reticulum-mitochondrial crosstalk: a novel role for the mitochondrial peptide humanin","volume":"12","author":"Sreekumar","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0800","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0805","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41598-020-80398-8","article-title":"The mitochondrial permeability transition phenomenon elucidated by cryo-EM reveals the genuine impact of calcium overload on mitochondrial structure and function","volume":"11","author":"Strubbe-Rivera","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.115703_bb0810","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115703_bb0815","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165228","article-title":"Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons","volume":"133","author":"Sun","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115703_bb0820","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/ijms18071576","article-title":"Interaction of mitochondria with the endoplasmic reticulum and plasma membrane in calcium homeostasis, lipid trafficking and mitochondrial structure","volume":"18","author":"Szyma\u0144ski","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0825","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s13311-023-01382-4","article-title":"Inhibition of ACSL4 alleviates parkinsonism phenotypes by reduction of lipid reactive oxygen species","volume":"20","author":"Tang","year":"2023","journal-title":"Neurotherap.: J. Am. Soc. Exper. NeuroTherapeut."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115703_bb0830","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1074\/jbc.M112.434183","article-title":"Phosphatidylethanolamine deficiency in mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology","volume":"288","author":"Tasseva","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0835","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","article-title":"FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson\u2019s disease","volume":"17","author":"Tian","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0840","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.2000.7333","article-title":"Abnormal mitochondrial morphology in sporadic Parkinson\u2019s and Alzheimer\u2019s disease cybrid cell lines","volume":"162","author":"Trimmer","year":"2000","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115703_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108079","article-title":"Mitofusin 2 in macrophages links mitochondrial ROS production, cytokine release, phagocytosis, autophagy, and bactericidal activity","volume":"32","author":"Tur","year":"2020","journal-title":"Cell Rep."},{"issue":"23","key":"10.1016\/j.expneurol.2026.115703_bb0850","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1074\/jbc.REV119.007500","article-title":"The role of lipids in \u03b1-synuclein misfolding and neurotoxicity","volume":"294","author":"Ugalde","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0855","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.040899","article-title":"Misfolded \u03b1-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells","volume":"13","author":"Ugalde","year":"2020","journal-title":"Dis. Model. Mech."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0860","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bbalip.2013.11.014","article-title":"MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond","volume":"1841","author":"Vance","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2\u20133","key":"10.1016\/j.expneurol.2026.115703_bb0865","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(02)01838-1","article-title":"The endoplasmic reticulum as an integrating signalling organelle: from neuronal signalling to neuronal death","volume":"447","author":"Verkhratsky","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0870","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/15548627.2022.2027193","article-title":"Ceramide-induced mitophagy impairs \u00df-oxidation-linked energy production in PINK1 deficiency","volume":"18","author":"Vos","year":"2022","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115703_bb0875","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1083\/jcb.201511044","article-title":"Cardiolipin promotes electron transport between ubiquinone and complex I to rescue PINK1 deficiency","volume":"216","author":"Vos","year":"2017","journal-title":"J. Cell Biol."},{"issue":"43","key":"10.1016\/j.expneurol.2026.115703_bb0880","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025347118","article-title":"Ceramide accumulation induces mitophagy and impairs \u03b2-oxidation in PINK1 deficiency","volume":"118","author":"Vos","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115703_bb0885","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115703_bb0890","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-018-0056-0","article-title":"PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1-parkin-mediated mitophagy","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115703_bb0895","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JPD-230363","article-title":"Twelve years of drug prioritization to help accelerate disease modification trials in Parkinson\u2019s disease: the international linked clinical trials initiative","volume":"14","author":"Wyse","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2026.115703_bb0900","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2023.06.002","article-title":"mTOR in programmed cell death and its therapeutic implications","volume":"71-72","author":"Xie","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.expneurol.2026.115703_bb0905","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fcell.2020.00428","article-title":"Endoplasmic reticulum-mitochondria contact sites and neurodegeneration","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2026.115703_bb0910","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.freeradbiomed.2024.10.284","article-title":"Astrocytic lactoferrin deficiency augments MPTP-induced dopaminergic neuron loss by disturbing glutamate\/calcium and ER-mitochondria signaling","volume":"225","author":"Xu","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"7146","key":"10.1016\/j.expneurol.2026.115703_bb0915","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nature05859","article-title":"RAS\u2013RAF\u2013MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0920","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115703_bb0925","article-title":"NRF2, a superstar of ferroptosis","volume":"12","author":"Yan","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.expneurol.2026.115703_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110604","article-title":"Dl-3-n-butylphthalide activates Nrf2, inhibits ferritinophagy, and protects MES23.5 dopaminergic neurons from ferroptosis","volume":"382","author":"Ye","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115703_bb0935","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/hmg\/ddz038","article-title":"Cellular \u03b1-synuclein pathology is associated with bioenergetic dysfunction in Parkinson\u2019s iPSC-derived dopamine neurons","volume":"28","author":"Zambon","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115703_bb0940","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11064-021-03262-9","article-title":"Benefits of Iron chelators in the treatment of Parkinson\u2019s disease","volume":"46","author":"Zeng","year":"2021","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115703_bb0945","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1021\/acschemneuro.3c00671","article-title":"Phospholipids and cholesterol determine molecular mechanisms of cytotoxicity of \u03b1-Synuclein oligomers and fibrils","volume":"15","author":"Zhaliazka","year":"2024","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0950","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","article-title":"PKC\u03b2II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis","volume":"24","author":"Zhang","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115703_bb0955","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.626","article-title":"New focuses on roles of communications between endoplasmic reticulum and mitochondria in identification of biomarkers and targets","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.115703_bb0960","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.freeradbiomed.2020.03.015","article-title":"Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson\u2019s disease","volume":"152","author":"Zhang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"19","key":"10.1016\/j.expneurol.2026.115703_bb0965","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddx269","article-title":"NCEH-1 modulates cholesterol metabolism and protects against \u03b1-synuclein toxicity in a C. elegans model of Parkinson\u2019s disease","volume":"26","author":"Zhang","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2026.115703_bb0970","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40035-024-00437-6","article-title":"Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson\u2019s disease","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb0975","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41420-023-01353-w","article-title":"Synergistic mechanism between the endoplasmic reticulum and mitochondria and their crosstalk with other organelles","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.expneurol.2026.115703_bb0980","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2015.12.035","article-title":"Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and \u03b1-synuclein aggregation in 6-OHDA induced parkinson\u2019s disease cell model","volume":"1633","author":"Zhang","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2026.115703_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137346","article-title":"Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson\u2019s disease","volume":"810","author":"Zheng","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2026.115703_bb0990","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.851135","article-title":"Glucocerebrosidase mutations cause mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease: pathogenesis and therapeutic implications","volume":"14","author":"Zheng","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"23","key":"10.1016\/j.expneurol.2026.115703_bb0995","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313042","article-title":"Targeting Ferroptosis in Parkinson\u2019s disease: mechanisms and emerging therapeutic strategies","volume":"25","author":"Zhou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.115703_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153582","article-title":"Upregulation of postsynaptic cAMP\/PKA\/CREB signaling alleviates copper(II)-induced oxidative stress and pyroptosis in MN9D cells","volume":"494","author":"Zhou","year":"2023","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115703_bb1005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","article-title":"Role of dopamine in the pathophysiology of Parkinson\u2019s disease","volume":"12","author":"Zhou","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"s2","key":"10.1016\/j.expneurol.2026.115703_bb1010","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.3233\/JAD-2010-100363","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"20","author":"Zhu","year":"2010","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115703_bb1015","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","article-title":"Temporal trends in the prevalence of Parkinson\u2019s disease from 1980 to 2023: a systematic review and meta-analysis","volume":"5","author":"Zhu","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.expneurol.2026.115703_bb1020","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9961628","article-title":"Ferritinophagy-mediated Ferroptosis involved in Paraquat-induced neurotoxicity of dopaminergic neurons: implication for neurotoxicity in PD","volume":"2021","author":"Zuo","year":"2021","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448862600066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448862600066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:11:48Z","timestamp":1779250308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448862600066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":204,"alternative-id":["S001448862600066X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115703","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction and disrupted neuronal lipid homeostasis in Parkinson\u2019s disease: Potential mechanisms and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115703"}}